[RNAZ] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[RNAZ] TransCode Therapeutics, Inc.
Announcement Date
31-Dec-2020
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 41.63%
YoY- -309.18%
Quarter Report
RNAZ's Result
RNAZ's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,330 2,771 -4,485 -802 -1,374 -127 -41 1374.50%
Tax -30 -3,126 3,983 369 854 -0 -0 -
NP -2,300 5,897 -4,485 -802 -1,374 -127 -41 1361.83%
Tax Rate - 112.83% - - - - - -
Total Cost 2,300 -5,897 4,485 802 1,374 127 41 1361.83%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -164.25 589.73 -278.07 -100.46 -172.19 -15.94 -6.53 756.79%
EPS Diluted -159.60 589.73 -278.07 -100.46 -172.19 -15.94 -6.53 740.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.